Buy NOLVADEX (TAMOXIFEN CITRATE) 10mg – ASTRAZENECA Online

Description

Chemical name:(Z)-2-[4-(1,2-Diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine
Formula: C26H29NO
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

NOLVADEX 10mg – ASTRAZENECA

Nolvadex, meticulously crafted by AstraZeneca, stands as a crucial medication in the treatment of breast cancer, particularly hormone receptor-positive breast cancer. Each tablet of Nolvadex contains 10 mg of Tamoxifen Citrate, a selective estrogen receptor modulator (SERM) renowned for its antiestrogenic effects.

Key Features:

1. Targeted Breast Cancer Therapy: Nolvadex is a cornerstone therapy for hormone receptor-positive breast cancer, which accounts for the majority of breast cancer cases. Tamoxifen Citrate, the active ingredient in Nolvadex, competes with estrogen for binding to estrogen receptors on breast cancer cells, thereby inhibiting estrogen-mediated tumor growth.
2. Adjuvant Treatment: Nolvadex is commonly used as adjuvant therapy following primary treatment (surgery, chemotherapy, or radiation therapy) to reduce the risk of breast cancer recurrence and improve long-term survival rates. By blocking the estrogenic stimulation of tumor cells, Nolvadex helps prevent the proliferation and spread of residual cancer cells.
3. Reduction of Breast Cancer Risk: In certain high-risk populations, such as women with a family history of breast cancer or those with benign breast conditions, Nolvadex may be prescribed for chemoprevention purposes. Tamoxifen Citrate has been shown to reduce the incidence of invasive breast cancer and ductal carcinoma in situ (DCIS) in these individuals.
4. Convenient Dosage Form: Each pack of Nolvadex contains 30 tablets, with each tablet containing 10 mg of Tamoxifen Citrate. The tablets are formulated for oral administration, providing convenient and precise dosing for patients undergoing breast cancer treatment or risk reduction therapy.
5. Manufactured by AstraZeneca: Nolvadex is manufactured by AstraZeneca, a global biopharmaceutical company committed to advancing oncology research and improving patient outcomes. AstraZeneca upholds rigorous quality standards to ensure the safety, efficacy, and reliability of Nolvadex and other pharmaceutical products.

Indications:

Nolvadex (Tamoxifen Citrate 10 mg Tablets) is indicated for the adjuvant treatment of hormone receptor-positive breast cancer in women following primary therapy, as well as for the reduction of breast cancer risk in high-risk individuals.

Usage Guidelines:

Nolvadex should be taken orally as directed by a healthcare professional experienced in the management of breast cancer. The recommended dosage may vary depending on factors such as disease stage, patient’s age, and menopausal status. Regular monitoring and follow-up appointments are essential to assess treatment response and manage potential side effects.

Experience the transformative impact of Nolvadex in optimizing breast cancer treatment and risk reduction strategies. With its targeted antiestrogenic therapy and proven efficacy, Nolvadex offers new hope and improved outcomes for individuals navigating the complexities of breast cancer care.